Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019

							Chronic Urticaria or Hives Therapeutics - Pipeline
Assessment and Market Forecasts to 2019
Summary

“Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
essential source of information and analysis on the global Chronic Urticaria Or Hives Therapeutics market. The
report identifies the key trends shaping and driving the global Chronic Urticaria Or Hives Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the report provides
valuable insights on the pipeline products within the global Chronic Urticaria Or Hives Therapeutics sector. This
report is built using data and information sourced from proprietary databases, primary and secondary research
and in-house analysis by Company team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Chronic Urticaria Or Hives
Therapeutics market. Its scope includes -
- Annualized seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) Chronic Urticaria
therapeutics market revenue data for 2006–2011, and 2011–2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed
and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Chronic Urticaria Or Hives
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently
researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the
implications for the Chronic Urticaria Or Hives Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Chronic Urticaria Or Hives Therapeutics
market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and
technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Chronic Urticaria Or
Hives Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and
companies likely to impact the global Chronic Urticaria Or Hives Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by
analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to
gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present
maximum opportunities for consolidations, investments and strategic partnerships.
- What the next big thing in the global Chronic Urticaria Or Hives Therapeutics market landscape? – Identify,
understand and capitalize.


1.1 List of Tables 5
1.2 List of Figures 6
2 CU Therapeutics - Introduction 7
2.1 Overview 7
2.2 Etiology 7
2.3 Pathophysiology 8
2.4 Epidemiology 9
2.5 Symptoms 9
2.6 Diagnosis 10
2.7 Treatment and Management Pattern 11
2.8 GlobalData Report Guidance 14
3 CU Therapeutics - Market Characterization 15
3.1 CU Therapeutics Market Size (2006-2011) – Global 15
3.2 CU Therapeutics Market Forecast (2011-2019) – Global 16
3.3 CU Therapeutics Market Size (2006-2011): The US 17
3.4 CU Therapeutics Market Forecast (2011-2019): The US 18
3.5 CU Therapeutics Market (2006-2011): France 19
3.6 CU Therapeutics Market Forecast (2011-2019): France 20
3.7 CU Therapeutics Market (2006-2011): Germany 21
3.8 CU Therapeutics Market Forecast (2011-2019): Germany 22
3.9 CU Therapeutics Market (2006-2011): Italy 23
3.10 CU Therapeutics Market Forecast (2011-2019): Italy 24
3.11 CU Therapeutics Market (2006-2011): Spain 25
3.12 CU Therapeutics Market Forecast (2011-2019): Spain 26
3.13 CU Therapeutics Market (2006-2011): The UK 27
3.14 CU Therapeutics Market Forecast (2011-2019): The UK 28
3.15 CU Therapeutics Market (2006-2011): Japan 29
3.16 CU Therapeutics Market Forecast (2011-2019): Japan 30
3.17 Drivers and Barriers for the CU Therapeutics Market 31
3.17.1 Drivers for the CU Therapeutics Market 31
3.17.2 Barriers for the CU Therapeutics Market 31
3.18 Opportunity and Unmet Need Analysis 32
3.19 Key Takeaway 33
4 CU Therapeutics - Competitive Assessment 34
4.1 Overview 34
4.2 Strategic Competitor Assessment 34
4.3 Product Profile for the Major Marketed Products in the CU Therapeutics Market 35
4.3.1 Allegra (fexofenadine hydrochloride) 35
4.3.2 Xyzal (levocetirizine dihydrochloride) 36
4.3.3 Clarinex (desloratadine) 37
4.3.4 Cetirizine 38
4.3.5 Bilastine 39
4.4 Key Takeaway 41
5 CU Therapeutics - Pipeline Assessment 42
5.1 Overview 42
5.2 Strategic Pipeline Assessment 42
5.3 CU Therapeutics Pipeline – Pipeline by Phases of Development 42
5.3.1 CU Therapeutics – Phase III Pipeline 43
5.3.2 CU Therapeutics – Phase II Pipeline 43
5.4 CU Therapeutics Market – Clinical Pipeline by Mechanism of Action 44
5.5 Technology Trends Analytical Framework 45
5.6 CU Therapeutics – Promising Drugs Under Clinical Development 46
5.7 Molecule Profile for Promising Drugs Under Clinical Development 46
5.7.1 Xolair (omalizumab) 46
5.8 Key Takeaway 47
6 CU Therapeutics - Clinical Trials Mapping 48
6.1 Clinical Trials by Region/Country (the US, EU5, and Japan) 48
6.2 Clinical Trials by Phase 49
6.3 Clinical Trials by Trial Status 50
6.4 Clinical Trials by Overall Sponsors 51
6.5 Prominent Sponsors 52
6.6 Key Companies Participating in Therapeutics Clinical Trials 53
7 CU Therapeutics - Strategic Assessment 54
7.1 Key Events Impacting the Future Market 54
7.2 CU Therapeutics: Implications for Future Market Competition 55
8 CU Therapeutics - Future Players 56
8.1 Introduction 56
8.2 Company Profiles 57
8.2.1 F. Hoffmann-La Roche Ltd. 57
8.2.2 Biofrontera AG (Subsidiary of DNAPrint Genomics, Inc.). 58
8.2.3 Sun Pharmaceutical Industries Limited. 58
9 CU Therapeutics - Licensing and Partnership Deals 61
10 CU Therapeutics - Appendix 62
10.1 Market Definitions 62
10.2 Abbreviations 62
10.3 METHODOLOGY 63
10.3.1 Coverage 63
10.3.2 Secondary Research 63
10.3.3 Forecasting 63
10.3.4 Primary Research 66
10.3.5 Expert Panel Validation 66
10.4 Contact Us 66
10.5 Disclaimer 66
10.6 Bibliography 67

1.1 List of Tables

Table   1: Features of Common Types of Urticaria 7
Table   2: First Line of Treatment in CU 12
Table   3: Second Line of Treatment in CU 12
Table   4: Rarely used drugs in CU 13
Table   5: CU Therapeutics Market, Global, Revenue ($m), 2006-2011 15
Table   6: CU Therapeutics Market, Global, Forecast ($m), 2011-2019 16
Table   7: CU Therapeutics Market, the US, Revenue ($m), 2006-2011 17
Table   8: CU Therapeutics Market, the US, Forecast ($m), 2011-2019 18
Table   9: CU Therapeutics Market, France, Revenue ($m), 2006-2011 19
Table   10: CU Therapeutics Market, France, Forecast ($m), 2011-2019 20
Table   11: CU Therapeutics Market, Germany, Revenue ($m), 2006-2011 21
Table   12: CU Therapeutics Market, Germany, Forecast ($m), 2011-2019 22
Table   13: CU Therapeutics Market, Italy, Revenue ($m), 2006-2011 23
Table   14: CU Therapeutics Market, Italy, Forecast ($m), 2011-2019 24
Table   15: CU Therapeutics Market, Spain, Revenue ($m), 2006-2011 25
Table   16: CU Therapeutics Market, Spain, Forecast ($m), 2011-2019 26
Table   17: CU Therapeutics Market, the UK, Revenue ($m), 2006-2011 27
Table   18: CU Therapeutics Market, the UK, Forecast ($m), 2011-2019 28
Table   19: CU Therapeutics Market, Japan, Revenue ($m), 2006-2011 29
Table   20: CU Therapeutics Market, Japan, Forecast ($m), 2011-2019 30
Table   21: CU Therapeutics – Strategic Competitor Assessment, 2011 34
Table   22: Changes in the First Week of a Clinical Trial in Patients with Chronic Idiopathic Urticaria 38
Table   23: Major Marketed Products Analysis in the CU Therapeutics Market, 2011 40
Table   24: CU Therapeutics Market – Phase III Pipeline, 2011 43
Table   25: CU Therapeutics Market – Phase II Pipeline, 2011 43
Table   26: Chronic Urticaria – Most Promising Drugs Under Clinical Development, 2011 46
Table   27: CU Therapeutics Market, Clinical Trials by Region, 2011 48
Table   28: CU Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 49
Table   29: CU Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 50
Table   30: CU Therapeutics Market, Global, Clinical Trials by Overall Sponsors, 2011 51
Table   31: CU Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 52
Table   32: CU Therapeutics Market, Global, Clinical Trials by Lead Sponsors, 2011 53
Table   33: CU Therapeutics Market – Clinical Pipeline by Company, 2011 56
Table   34: Pipeline Molecules 2011 57
Table   35: Pipeline Products 2011 58
Table   36: Pipeline Product 2011 60
Table 37: Licensing and Partnership Deals 61

1.2 List of Figures

Figure   1:   Mast Cell Degranulation in CU 9
Figure   2:   Diagnosis Algorithm for CU 10
Figure   3:   Diagnosis Algorithm for CU 11
Figure   4:   CU Therapeutics Market, Global, Revenue ($m), 2006-2011 15
Figure   5:   CU Therapeutics Market, Global, Forecast ($m), 2011-2019 16
Figure   6:   CU Therapeutics Market, the US, Revenue ($m), 2006-2011 17
Figure   7:   CU Therapeutics Market, the US, Forecast ($m), 2011-2019 18
Figure   8:   CU Therapeutics Market, France, Revenue ($m), 2006-2011 19
Figure   9: CU Therapeutics Market, France, Forecast ($m), 2011-2019 20
Figure   10: CU Therapeutics Market, Germany, Revenue ($m), 2006-2011 21
Figure   11: CU Therapeutics Market, Germany, Forecast ($m), 2011-2019 22
Figure   12: CU Therapeutics Market, Italy, Revenue ($m), 2006-2011 23
Figure   13: CU Therapeutics Market, Italy, Forecast ($m), 2011-2019 24
Figure   14: CU Therapeutics Market, Spain, Revenue ($m), 2006-2011 25
Figure   15: CU Therapeutics Market, Spain, Forecast ($m), 2011-2019 26
Figure   16: CU Therapeutics Market, the UK, Revenue ($m), 2006-2011 27
Figure   17: CU Therapeutics Market, the UK, Forecast ($m), 2011-2019 28
Figure   18: CU Therapeutics Market, Japan, Revenue ($m), 2006-2011 29
Figure   19: CU Therapeutics Market, Japan, Forecast ($m), 2011-2019 30
Figure   20: Opportunity and Unmet Need in the CU Therapeutics Market, 2011 33
Figure   21: CU Therapeutics Pipeline by Phase of Clinical Development, 2011 42
Figure   22: CU Therapeutics Market – Clinical Pipeline by Mechanism of Action, 2011 44
Figure   23: Technology Trends Analytic Framework for the CU Therapeutics Pipeline, 2011 45
Figure   24: Technology Trends Analytic Framework for the CU Therapeutics Pipeline, 2011 46
Figure   25: CU Therapeutics Market – Clinical Trials by Region, 2011 48
Figure   26: CU Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 49
Figure   27: CU Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 50
Figure   28: CU Therapeutics Market, Global, Clinical Trials by Overall Sponsors, 2011 51
Figure   29: CU Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 52
Figure   30: CU Therapeutics Market, Global, Clinical Trials by Top Companies, 2011 53
Figure   31: Drivers and Barriers of the CU Therapeutics Market 54
Figure   32: Implications for Future Market Competition in the CU Therapeutics Market, 2011 55
Figure 33: GlobalData Market Forecasting Model 65

Company Mentioned:


F. Hoffmann-La Roche Ltd.
Biofrontera AG (Subsidiary of DNAPrint Genomics, Inc.).
Sun Pharmaceutical Industries Limited.


For more information, please visit:

http://www.aarkstore.com/reports/Chronic-Urticaria-or-Hives-Therapeutics-Pipeline-
Assessment-and-Market-Forecasts-to-2019-198805.html

Or email us at contact@aarkstore.com or call +918149852585

More Reports

Solar Module Recycling - A Necessary Step to Maximize Environmental Benefits of Solar PV Industry
Geothermal Power - Global Market Size, Technology Analysis, Regulations and Key Country Analysis to 2020
Advanced Clean Energy Storage Devices - Global Market Size, Market Analysis by Major Storage Device, and
Competitive Landscape to 2020
Thin-Film PV - Global Market Size, Price Analysis, Regulations and Competitive Landscape to 2020
Wind Operations & Maintenance (O&M) Market - Global Market Size, Share by Component, Competitive
Landscape and Key Country Analysis to 2020
Compact Fluorescent Lamp (CFL) Market - Global Market Size, Price Analysis, Regulations and Key Countries
Analysis to 2020
Biofuels (Biodiesel and Bioethanol) Market - Global Production, Regulations, Export-Import Analysis and Key
Country Analysis to 2020
Wind Repowering - Capacity, Generation and Cost-Benefit Analysis to 2020
Oil and Gas Capital Expenditure Outlook, 2012
Offshore Oil and Gas Developments in Asia-Pacific - Burgeoning Energy Demand Drives Exploration and
Production Activities
Strategic Pipelines Set to Change Geopolitical and Demand Supply Paradigm in the Global Oil and Gas Industry
Coal Seam Gas (CSG/CBM) in Asia, 2011 - Market Analysis, Investment Scenario, Competitive Landscape and
Production Forecasts to 2015
Refining Industry in Asia-Pacific - Market Analysis, Competitive Landscape and Capacity Forecasts to 2016
Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape
and Planned Projects to 2015
Bakken Shale, 2011 - Oil Shale Market Analysis and Forecasts to 2020
Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020
Niobrara Shale in the US, 2012 - Oil Shale Market Analysis and Forecasts to 2020
Utica Shale, 2012 - Oil and Gas Market Analysis and Forecasts to 2020
Haynesville Shale in the US, 2012 - Gas Shale Market Analysis and Forecasts to 2020
Montney Shale in Canada, 2012 - Gas Shale Market Analysis and Forecasts to 2020
Nuclear Condensate and Feed Water Pumps - Global Market Size, Pricing, Regional Analysis and Competitive
Landscape to 2020
Nuclear Moisture Separator Reheaters Market - Global Market Size, Pricing Analysis, Regional Analysis and
Competitive Landscape to 2020
Plant Life Extension (PLEX) and Plant Life Management (PLIM) for Nuclear Reactors - Global Landscape Analysis
to 2020
Phase Shifting Transformers for Power Transmission - Global Market Size, Average Pricing, Equipment Market
Share and Competitive Landscape Analysis to 2020
High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing, Equipment
Market Share and Competitive Landscape Analysis to 2020
Steam Turbines in Asia-Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive
Landscape Analysis to 2020
Shunt Reactor for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and
Competitive Landscape Analysis to 2020
Power Boilers in Asia Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive
Landscape Analysis to 2020
Gas Turbines in BRIC (Brazil, Russia, India and China) - Market Size, Average Pricing, Equipment Market Share
and Competitive Landscape Analysis to 2020
Heat Recovery Steam Generator (HRSG) Market in Asia-Pacific Region - Market Size, Pricing Analysis,
Equipment Market Share and Competitive Landscape Analysis to 2020
High Voltage Direct Current (HVDC) Cables - Global Market Size, Average Pricing, Equipment Market Share and
Competitive Landscape Analysis to 2020
Gas Turbines for Thermal Power - Global Market Size, Average Pricing, Equipment Market Share and
Competitive Landscape Analysis to 2020
Wireless Communication Modules for Smart Meters - Market Analysis and Forecasts to 2020
Smart Grid Vendor Landscape Analysis - Strategic Activity Analysis and Outlook to 2015
In-Home Displays for Energy Management - Market Analysis and Forecasts to 2020
Smart Grid Market and Technology Outlook - Industry Trends and Competitive Analysis
Smart Grid Landscape in Europe - Market Size, Key Issues, Regulations, Investment Analysis and Outlook to
2020
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to
2018
Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Rhabdomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts
to 2019
Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Lyme Disease - Pipeline Assessment and Market Forecasts to 2018
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Graves’ Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019
Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Waldenström’s Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market
Forecasts to 2017
Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive
Landscape and Market Forecasts to 2017
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market
Forecasts to 2017
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to
2017
Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive
Landscape and Market Forecasts to 2017
Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Electrosurgical Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Compression Therapy - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Wound Closure Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to
2017
Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs
and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South
Africa) to 2017
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Wound Closure Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Ostomy Drainage Bags Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
to 2017
Flexible Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Rigid Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Capsule Endoscope Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017


Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://www.emarketreports.com

Follow us on twitter: http://twitter.com/aarkstoredotcom

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstoreenterprise

http://www.aarkstore.com/feeds/globaldata.xml